Associations between lifetime classic psychedelic use and markers of physical health
Otto Simonsson, James D. Sexton, Peter S. Hendricks
Journal of Psychopharmacology March 9, 2021 DOI: 10.1177/0269881121996863 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational cross-sectional study Peer reviewed |
|---|---|
| Sample size | 171,766 |
| Population | Adults aged 18 or above in the United States |
| Keywords | Overweight Body mass index Odds ratio Mental health Gerontology Physical health Logistic regression Demography |
| Citations | 75 |
| Key findings | Lifetime classic psychedelic use was associated with higher odds of better self-reported overall health and lower odds of being overweight or obese. |
Abstract
Background: In recent years, there has been significant research on the mental health effects of classic psychedelic use, but there is very little evidence on how classic psychedelics might influence physical health.
Aims: The purpose of the present study was to investigate the associations between lifetime classic psychedelic use and markers of physical health.
Methods: Using data from the National Survey on Drug Use and Health (2015-2018) with 171,766 (unweighted) adults aged 18 or above in the United States, the current study examined the associations between lifetime classic psychedelic use and three markers of physical health (self-reported overall health, body mass index, and heart condition and/or cancer in the past 12 months) while controlling for a range of covariates.
Results: Respondents who reported having tried a classic psychedelic at least once in their lifetime had significantly higher odds of greater self-reported overall health and significantly lower odds of being overweight or obese versus having a normal weight. The association between lifetime classic psychedelic use and having a heart condition and/or cancer in the past 12 months approached conventional levels of significance, with lower odds of having a heart condition and/or cancer in the past 12 months for respondents who had tried a classic psychedelic at least once.
Conclusion: The results of the present study suggest that classic psychedelics may be beneficial to physical health. Future research should investigate the causal effects of classic psychedelics on physical health and evaluate possible mechanisms.
Citations in the library
Cited by 65
- Prevalence and associations of challenging, difficult or distressing experiences using classic psychedelics. Journal of Affective Disorders April 1, 2023
- Psychedelics, Sociality, and Human Evolution Frontiers in Psychology September 29, 2021
- Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample. Journal of Psychopharmacology August 1, 2022
- Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment Neuropharmacology January 13, 2023
- Pattern breaking: a complex systems approach to psychedelic medicine Neuroscience of Consciousness 2023
and 60 more in the library
Cites 35
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder JAMA Psychiatry November 4, 2020
- Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacology November 8, 2017
- Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction Journal of Psychopharmacology September 11, 2014
- Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression Journal of Humanistic Psychology June 19, 2017
and 30 more in the library